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Cryptococcus neoformans causes life-threatening diseases mainly in
immunosuppressed hosts such as AIDS patients; C. gattii causes disseminated
infections even in healthy hosts. To identify the possible molecular mechanisms
underlying this difference in virulence, we investigated the survival and histopathology of
lung tissue in wild-type and CD4-depleted mice infected with C. neoformans H99 and
C. gattii JP02 (the highly virulent strain isolated in Japan); we then compared dendritic
cell (DC) cytokine release responses to different cell fractions from these two strains.
JP02-infected mice exhibited shorter survival and fewer inflammatory cells in the lung
than H99-infected control mice. Depletion of CD4-related cellular immunity reduced
survival of H99-infected mice but had no effect on the survival or inflammatory cell
infiltration in JP02-infected mice, suggesting that JP02 evades immune detection. To
identify the molecule(s) conferring this difference, we measured cytokine production from
murine DCs co-cultured with H99 and JP02 in vitro. The levels of inflammatory cytokines
from DCs treated with intact JP02 cells, the extracted capsule, secreted extracellular
polysaccharides, and purified glucuronoxylomannan (GXM) were markedly lower than
those induced by intact H99 cells and corresponding H99 fractions. Structural analysis
of GXM indicated that JP02 altered one of two O-acetyl groups detected in the H99
GXM. Deacetylated GXM lost the ability to induce inflammatory cytokine release from
DCs, implicating these O-acetyl groups in immune recognition. We conclude that the
highly virulent C. gattii processes a structural alteration in GXM that allows this pathogen
to evade the immune response and therefore elimination.
Keywords: Cryptococcus gattii, Cryptococcus neoformans, capsule, glucuronoxylomannan, structure,
O-acetylation, innate immune responses, dendritic cells
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INTRODUCTION
Life-threatening diseases caused by Cryptococcus neoformans in
immunosuppressed hosts such as AIDS patients occur at a global
rate of approximately 1 million cases per year (Park et al., 2009).
In contrast, infection by its sibling species C. gattii is much less
common in AIDS patients but is thought to be more virulent
than C. neoformans and causes disseminated infections even in
healthy hosts (Galanis et al., 2009). Since 1999, more than 300
C. gattii infections have been reported in British Columbia and
these cases were generally more severe than cryptococcosis due
to C. neoformans, including a case of cerebral cryptococcoma
(Galanis et al., 2010; BC Centre for Disease Control, 2015). So
far, the difference in virulence between conventional cryptococcal
pathogens and hypervirulent strains is under-investigated.
The difference in virulence between C. neoformans H99 and
C. gattii R265, (the C. gattii strain was clinically isolated during
the Canadian outbreak, Kidd et al., 2004) was characterized in
previous studies. One study in CD4C/HIVMutA transgenic mice
showed that HIV-1 transgene expression consistently augments
susceptibility to H99, but not to R265 infection and reduces
the pulmonary inflammatory cell response by both depletion
of immune cells and diminished production of chemokines
(Leongson et al., 2013). Cheng et al. found that neutrophil
infiltration and inflammatory cytokine production were lower in
the lungs of wild-type mice infected with R265 compared with
mice infected with H99 (Cheng et al., 2009). Accumulation of
immune cells in the murine lung was lower in response to R265
infection than H99 infection (Okubo et al., 2013).
In the infectious state, bothH99 and R265 form a thick capsule
(Leongson et al., 2013) thought to be important for resistance
against host innate immunity, such as evasion of phagocytosis
(Buchanan and Murphy, 1998; Zaragoza et al., 2009). Acapsular
strains of C. neoformans are less virulent than encapsulated
ones because acapsular strains are directly exposed to the cell
surfaces of immunocytes and thus strongly induce host immune
responses (Buchanan and Murphy, 1998; Zaragoza et al., 2009).
However, the factors responsible for the differences in immune
response between highly encapsulatedC. neoformans andC. gattii
are still unknown.
Cryptococcal capsule is composed primarily of
glucuronoxylomannan (GXM), which comprises more than
90% of the capsule’s polysaccharide mass (Zaragoza et al., 2009).
It is also secreted abundantly into the ambient environment
(Cherniak and Sundstrom, 1994). The roles of GXM in
cryptococcal virulence have been reported in C. neoformans.
The GXM is important to abolish host immunity by inhibiting
binding of antibodies and complement C3 (Young and Kozel,
1993; Cherniak and Sundstrom, 1994). On the other hand,
it has been also shown that GXM can induce expression of
inflammatory cytokines, such as TNF-α and IL-6, from human
immune cells (Delfino et al., 1996, 1997; Retini et al., 1996;
Walenkamp et al., 1999). However, the differences in GXM
structure between C. neoformans and highly virulent C. gattii are
still unclear.
The C. gattii strain JP02 was isolated together with JP01,
the first genotype VGIIa strain isolated in Japan, from the
same patient in 2007 (Okamoto et al., 2010). The strain JP02
belongs to the genotype VGIIc, and its virulence against mice
is higher than R265 (our unpublished data). In the present
study, we first compared virulence and induction of protective
inflammation between C. gattii JP02 and C. neoformans H99
in both wild type and mice depleted of CD4-positive cells (a
model of immune compromise) using an anti-CD4 antibody.
Furthermore, we identified one capsule constituent, GXM, likely
involved in determining the difference in murine dendritic cell
immune response between JP02 and H99 cells by comparing
in vitro cytokine release in response to intact cells and various
subcellular fractions.
MATERIALS AND METHODS
Ethics
All experiments on mice were conducted according to the
protocols approved by the Animal Care and Use Committee
of the National Institute of Infectious Diseases, Japan (approval
number 114029, 213054, and 215046).
Strains
C. neoformans H99 and C. gattii JP02 were routinely cultured
in yeast extract-peptone-dextrose medium (YPD, BD) at
30◦C. To obtain the capsular polymeric substances (CPS)
and extracellular polysaccharides (EPS), cells were grown in
modified yeast nitrogen broth (mYNB) [YNB without amino
acids (BD) supplemented with complete supplement mixture
(FORMEDIUM) and 0.5% (wt/vol) of D-glucose].
Mice
C57BL/6 female mice were obtained from Japan SLC (Shizuoka,
Japan) and maintained under specific pathogen-free conditions
at the National Institute of Infectious Diseases.
Dendritic Cells
The JAWSII cell line (ATCC R© CRL-11904TM) derived from the
bone marrow of the p53 KO C57BL/6 mouse was obtained
from the American Type Culture Collection. Isolation of primary
dendritic cells derived from the bonemarrow (BMDCs) of female
C57BL/6J mice was described previously (Ueno et al., 2015).
Infection Study
Eight-week-old mice were injected intraperitoneally with 300µg
monoclonal anti-CD4 antibody (purified anti-mouse CD4
antibody clone GK1.5, Biolegend, MA) or control antibody
(purified Rat IgG2b, κ Isotype Ctrl, Biolegend) on the day prior
to pathogen inoculation and with 100µg on days 6, 13, and 20.
Strains H99 and JP02 were cultured in YPD medium overnight,
recovered by centrifugation, and resuspended in PBS. Mice were
anesthetized with isoflurane, and 50µl of a fungal suspension
containing 5.0×103 or 5.2×103 cells was injected intratracheally
using a 24-gauge indwelling needle (TOP Corporation, Japan).
For survival analysis, mice were monitored daily for 34
days after infection. For histopathological examination and to
determine fungal burden, mice were euthanized by carbon
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 January 2016 | Volume 5 | Article 101
Urai et al. Cryptococcus gattii Glucuronoxylomannan
dioxide inhalation 2 weeks after infection and the lungs were
harvested. Lungs were homogenized using a nylon mesh (70µm;
BD Falcon, NJ.) in 2ml of PBS. The homogenates were diluted
and spread onto YPD plates. The plates were incubated at 30◦C
and cryptococcal colonies were counted at 24 h post incubation.
Histological analyses were performed as described previously
(Okubo et al., 2013).
To confirm whether CD4+ T cells were depleted by anti-
CD4 antibody treatment, flow cytometry analysis was performed.
The blood was sampled from orbital sinus of mice on 6 days
before and 2, 6, and 13 days after the first administration of
monoclonal anti-CD4 antibody or control antibody. Red blood
cells were lysed with lysis buffer [9 volumes of 0.83% (wt/vol)
NH4Cl and 1 volume of 200mMTris-HCl, pH 7.6]. Residual cells
were then stained for flow cytometry analysis. All antibodies and
buffer used for cell staining were from Biolegend. Fc receptors
were blocked with an anti-CD16/32 antibody (clone 93) and
then, cells were stained with anti-CD4 (clone RM4-4) and anti-
TCRβ (clone H57-597) antibodies. Data were acquired with a BD
FACSCalibur™ flow cytometer (BD Bioscience) and analyzed by
using FlowJo software (TreeStar Inc.).
Isolation of CPS and EPS Fractions, and
Purification of Glucuronoxylomannan
(GXM) from the EPS Fraction
The H99 and JP02 strains were grown in mYNB at 30◦C with
shaking for 5 days. Cryptococcal cells were killed by heating
at 105◦C for 30min and EPS was extracted from the culture
medium supernatant as described previously (Urai et al., 2006),
except using the Sevag method instead of phenol–chloroform
treatment (Staub, 1965). The CPS fraction was extracted after
EPS extraction as described previously (Bryan et al., 2005), with
some modifications. Briefly, cells were delipidated by the Forch
method (Folch et al., 1957), and capsule components extracted
from the remaining cellular material using dimethyl sulfoxide.
After centrifugation, supernatants were collected and dialyzed
against MilliQ water.
GXM was purified from the EPS fraction by DEAE-Toyopearl
650M column chromatography as described previously (Urai
et al., 2007). Fractions containing saccharides were monitored
by the phenol–H2SO4 method (DuBois et al., 1956) and dialyzed
against MilliQ water.
EPS extraction from homogenate of murine lung infected with
cryptococci followed the same procedure as described above with
the exception of dialysis.
Measurement of Cytokine Release from
Dendritic Cells
JAWSII cells (2 × 105 cells/mL) were incubated with intact
cryptococcal cells, CPS, EPS, or GXM in minimum essential
medium Eagle α (Sigma) with complete supplement mixture
[10% (vol/vol) heat-inactivated fetal bovine serum (FBS,
EQUITECH BIO), 1% (vol/vol) penicillin-streptomycin-L-
glutamine solution (Wako; 10,000 units/ml penicillin G,
10mg/ml streptomycin, 29.2mg/ml L-glutamine, and 8.5mg/ml
NaCl), 1% (vol/vol) 200mM L-glutamine solution (Wako),
1% (vol/vol) 100mM sodium pyruvate solution (Gibco BRL),
and 5 ng/ml mouse granulocyte-macrophage colony-stimulating
factor (mGM-CSF, PeproTech Inc.) at 37◦C under 5% CO2
for 24 h. Culture medium was harvested and centrifuged, and
the supernatants were subjected to cytokine production assays
as described below. The procedures for analysis of cytokine
release from DCs derived from bone marrow (BMDCs) (1× 106
cells/mL) were similar except that cells were cultured and treated
in complete RPMI 1640 medium (Sigma) supplemented with
10% (vol/vol) FBS, 1% (vol/vol) streptomycin-penicillin solution
(Sigma; 10,000 units penicillin and 10mg/ml streptomycin),
44µM 2-mercaptoethanol, and 10 ng/ml mGM-CSF (PeproTech
Inc.).
Live cryptococcal cells were collected by centrifugation from
overnight culture in YPD medium and resuspended in PBS.
Heat-killed cryptococcal cells were prepared by heating the cell
suspension in PBS to 65◦C for 1 h.
Release rates of IL-6, IL-12p40, and TNF-α were measured
using Becton Dickinson Laboratory murine IL-6, IL-12p40,
and TNF-α enzyme-linked immunosorbent assay (ELISA) kits
according to the manufacturer’s instructions. Culture medium of
non-treated dendritic cells was used as the control of cytokine
production.
Structural Analysis of GXM
Monosaccharide analysis was performed as described previously
(Urai et al., 2006). Briefly, GXM was hydrolyzed by 4M TFA at
100◦C for 3 h, and the monosaccharides obtained were labeled
with aminobenzoic acid ethyl ester (ABEE) and analyzed by
high performance liquid chromatography (HPLC) (1500 HPLC
system, Waters, Milford, MA). All nuclear magnetic resonance
(NMR) spectra were recorded at 500 MHz (1H) with an ECA 500
instrument (JEOL Ltd. Tokyo, Japan). Chemical shifts are given
in δ units with acetone (δ1H 2.23) used as an external reference
for samples measured in D2O solutions. O-deacetylation and
sonication of GXMwere performed as described previously (Urai
et al., 2006).
Statistical Analysis
SPSS software, version 20.0 (IBM Japan, Tokyo, Japan), was used
for all statistical analyses. Normality of distribution and equality
of variance were assessed using the Shapiro-Wilk and Levene
tests, respectively. P values < 0.01 were considered significant.
RESULTS
JP02 Shows Higher Virulence than H99 in a
Murine Pulmonary Infection Model
To identify the possible mechanisms conferring the higher
virulence of C. gattii JP02 compared to C. neoformans H99,
we first measured survival rates of C57BL/6J mice following
intratracheal pathogen injection. Control mice infected with
JP02 exhibited significantly shorter median survival than those
infected with H99 (21 vs. 30 days) (Figure 1A). The number
of yeast cells recovered from the lung tissue of JP02-infected
mice was 10 times higher than that recovered from H99-infected
mice (Figure 1B). Both H99 and JP02 formed thick capsules as
revealed by microscopic observation of India ink-stained lung
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FIGURE 1 | Greater virulence and mortality of Cryptococcus gattii JP02
infection compared to Cryptococcus neoformans H99 infection and
independence from CD4 cell-mediated immunity. (A) Shorter survival of
mice infected with JP02 compared with H99-infected mice (n = 8). Some mice
were depleted of CD4-positive cells by an anti-CD4 injection before infection.
The survival from H99 infection was shorter in CD4-depleted mice compared
with that in CD4-positive control mice, while CD4 depletion had no effect on
the survival from JP02 infection. (B) Fungal burden was substantially higher in
the lungs of JP02-infected mice compared with the lungs of H99-infected
mice. Results are representative of two individual experiments with n = 5 for
each experiment (means ± standard deviations, SD). (C) Capsule formation as
evaluated by India ink staining of infected lung homogenates showing thick
capsule formation by both species. Bar, 10µm. Survival curves were
compared by log-rank test and the means of fungal burden were compared by
the unpaired t-test. *P < 0.01; NS, not significant.
homogenate (Figure 1C), so capsule formation does not appear
to account for the difference in virulence between strains.
Survival from H99 Infection was Reduced
in CD4-Depleted Mice, While CD4(+)
Cell-Mediated Immunity had No Effect on
JP02 Infection
To model infection under cellular immune deficiency, such
as that associated with HIV infection, CD4-positive cells
were depleted by injection of anti-CD4 antibody. The
CD4+ cell depletion was confirmed by the flow cytometry
analysis (Figure S1). These CD4-depleted mice exhibited
significantly shorter survival following H99 infection than
control H99-infected mice, while there was no significant
difference in survival between CD4-depleted and non-
depleted mice following JP02 infection (Figure 1A). These
results suggest that H99 causes more severe infection in
immunecompromised hosts while JP02 can cause severe
infection even in immunocompetent hosts. Furthermore,
suppression of CD4T cell-mediated immunity had no effect on
survival or histopathologic signs of lung inflammation (below),
suggesting that JP02 may not be recognized by the cell-mediated
immune system.
Inoculation with JP02 Induced a Weaker
Protective Inflammatory Response in the
Murine Lung than H99
Low-power fields of lung sections from control mice infected
with H99 showed multiple well-demarcated nodular lesions but
no alveolar airspace variation (Figure 2A). The lung sections
of CD4-depleted mice infected with H99 also showed well-
demarcated nodular lesions, but these were enlarged compared
to control H99-infected mice. In contrast to H99-infected mice,
CD4 depletion did not affect the histopathological features of
murine lung infected with JP02. Neither lung sections from
control JP02-infected mice nor CD4-depleted JP02-infected mice
exhibited nodular lesions, but both showed eccentric pulmonary
enlargement and alveolar airspace variation.
High-power fields of pulmonary sections from control mice
infected with H99 showed numerous multinucleated giant cells
(MGCs) with well-developed nuclei (Figure 2B). Yeast cells were
observed only in the nodular lesions, and the surfaces of yeast
cells were well-stained by alcian blue. These results suggest
that H99 cells are recognized by host immune cells despite
encapsulation. Sections of CD4-depleted murine lung infected
with H99 showed MGCs with somewhat foamy cytoplasm and a
smaller number of nuclei. However, yeast cells were still observed
only in the nodular lesions. In contrast, pulmonary sections from
both control and CD4-depleted JP02-infected mice exhibited
no inflammatory cell infiltration. No MGCs were observed in
sections from either CD4-depleted or non-depleted JP02-infected
lungs. Numerous yeast cells with surfaces well-stained by alcian
blue were diffusely spread throughout the alveoli. Furthermore,
alveolar airspaces of JP02-infected murine lung were filled with
large amounts of an acidic substance, probably GXM secreted
from JP02 cells as revealed by alcian blue staining (Figure 2B).
Thus, the JP02 strain did not appear to be recognized by lung
immunocytes. Since capsule formation is thought to be critical
for resistance against host innate immunity, we speculated that
some capsule component present and/or secreted by JP02 but not
H99 cells confers resistance against recognition by immune cells.
To assess this possibility, we first estimated the amount of
secreted EPS from H99 and JP02 cells in murine lung using the
phenol–H2SO4 method against polysaccharides extracted from
lung homogenate. Consistent with the results of alcian blue
staining, a greater amount of polysaccharide was detected in the
homogenate of JP02-infected murine lung compared to H99-
infected lung (Table S1). These results indicate that JP02 cells
secrete a larger amount of GXM in murine lung, which may
interfere with recognition by host immune cells.
H99 Induces Greater Interleukin-6 Release
from Murine Dendritic Cells than JP02
One possible reason for the shorter overall survival of JP02-
infected mice as well as the unaltered survival by CD4-depletion
is impaired pathogen recognition. Pathogen recognition by
phagocytes is the first step in the immune response and
is required for induction of CD4T cell-mediated immunity.
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FIGURE 2 | Histopathological differences between H99- and JP02-infected lungs suggest less protective inflammation induced by JP02. Lung paraffin
sections were prepared from mice on day 14 after intratracheal infection, stained with hematoxylin-eosin (HE) or alcian blue (AB), and examined at magnifications of
(A) ×40 (bar, 1mm) and (B) ×400 (bar, 100µm) under a light microscope. (A) Lung sections of control and CD4-depleted mice infected with H99 showed
well-demarcated nodular lesions (arrows), but these were enlarged in CD4-depleted mice. In contrast, neither the lung sections of control nor CD4-depleted mice
infected with JP02 exhibited nodular lesions, but both showed eccentric pulmonary enlargement and alveolar airspace variation. (B) Lung sections of control and
CD4-depleted mice infected with H99 showed numerous MGCs (arrows). Yeast cells (arrow heads) were observed only in the nodular lesions, and these surfaces
were well-stained by alcian blue. In contrast, the lung sections of control and CD4-depleted JP02-infected mice exhibited no inflammatory cell infiltration. Numerous
yeast cells were observed in the alveoli, and its airspaces were filled with large amounts of an acidic substance stained by alcian blue.
Therefore, we tested whether mouse JAWSII DCs could
recognize live H99 and JP02 cells in co-culture by measuring
IL-6 released into the culture supernatant, a well-described
response of immune cells in the presence of stimulants such
as lipopolysaccharide. Whereas live H99 cells stimulated IL-
6 production from JAWSII DCs, live JP02 cells did not
(Figure 3A). However, it is possible that live JP02 cells suppress
IL-6 production by cytotoxicity or by suppressive signals. To
examine the first possibility, we cultured JAWSII DCs with heat-
killed JP02 cells or H99 cells. Although heat-killed H99 cells
still induced IL-6 production from JAWSII cells, heat-killed
JP02 cells did not (Figure 3B). In addition, IL-6 production
induced by H99 cells was not suppressed by co-inoculation with
JP02 cells. Collectively, these results suggest that JP02 is not
recognized by JAWSII DCs and that the hypervirulent C. gattii
possesses molecular mechanism to evade recognition by host
innate immune cells.
Capsule and Extracellular Polysaccharides
from H99 Cells but Not JP02 Cells Induce
Il-6 Production from Murine Dendritic Cells
We next conducted experiments to identify molecular
component(s) on the cell surface or secreted into the extracellular
space that contribute to the evoked release of proinflammatory
cytokines from DCs (and that may be less potent or absent in
JP02 cells). Cryptococci express cell surface polysaccharides and
previous studies have shown that cryptococcal polysaccharides
induce production and release of proinflammatory cytokines
(Delfino et al., 1996, 1997; Retini et al., 1996; Walenkamp et al.,
1999). We thus extracted CPS and EPS from H99 and JP02
cells, and applied them to JAWSII DCs. The CPS extract from
H99 cells induced IL-6 production from JAWSII DCs, although
IL-6 production was attenuated at higher doses, i.e., 500µg /mL
(Figure 4A). On the other hand, CPS extract from JP02 cells did
not induce measureable IL-6 production at any concentration
tested. These results suggest that the JP02 CPS fraction is far
less potent at inducing the inflammatory response than that
from H99 cells. That higher H99 CPS concentrations also did
not induce robust cytokine release may be explained by the
formation of a filamentous matrix in the medium as revealed by
microscopic observation (not shown).
Next, the cytokine-inducing capacity of JP02 EPS purified
from culture supernatant was compared with that of H99 EPS.
Amounts of EPS obtained per culture volume were similar
between H99 and JP02 cells (Table 1). The EPS mixture
purified from H99 induced IL-6 production in a dose-dependent
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FIGURE 3 | Lower IL-6 release from JAWSII dendritic cells in response
to live or heat-killed JP02 cells compared with live or heat-killed H99
cells. JAWSII cells (2× 105 cells/mL) were incubated with live (MOI = 1) or
heat-killed (MOI = 5) cryptococcal cells for 24 h, and supernatant was
obtained for ELISA. (A) Incubation with live cells. (B) Incubation with
heat-killed cells. H99 + JP02 means co-incubation with heat-killed H99 and
heat-killed JP02 cells (MOI = 5, each). The experiments were performed in
triplicate (means ± SD). Treatment group means were compared by the
unpaired t-test, except for vs. H99 in (B), which were compared by the
Mann–Whitney U-test. *P < 0.01; NS, not significant.
manner, while that from JP02 did not (Figure 4B). To exclude
the possibility that IL-6 in the supernatant resulted from
lipopolysaccharide contamination in the EPS extract, the cationic
antibiotic polymyxin B, which binds strongly to LPS, was added
to the JAWSII culture with the EPS mixture. However, there was
no effect of polymyxin B on EPS-induced IL-6 release (Figure
S2). To determine whether the JP02 EPS mixture suppresses IL-
6 production, JP02 EPS were mixed with H99 EPS and added to
JAWSII DCs. However, the presence of JP02 EPS did not suppress
IL-6 release stimulated by H99 EPS (Figure 4C). These results
suggest that JP02 EPS are not recognized and so do not induce
cytokine release from dendritic cells.
Difference in Glucuronoxylomannan
O-acetylation between H99 and JP02 Cells
The extracted EPS fraction is a mixture of several
polysaccharides, so we performed anion column
chromatography to separate individual components and identify
those with structural differences between H99 and JP02. The
EPS fractions from H99 and JP02 cells showed similar elution
profiles and contained one major acidic subfraction (P). The P1
subfraction from H99 EPS and P2 subfraction from JP02 EPS
FIGURE 4 | Lower IL-6 release from JAWSII cells in response to CPS
and EPS fractions of JP02 cells compared to CPS and EPS fractions of
H99 cells. JAWSII cells (2× 105 cells/mL) were incubated with CPS or EPS
for 24 h, and supernatant obtained for ELISA. (A) CPS; (B) EPS, and (C)
co-incubation with EPS from both H99 and JP02 (50µg/mL, each). The
experiments were performed in triplicate (means ± SD). Treatment group
means were compared by the unpaired t-test, except for vs. CPS 500µg/mL,
which were compared by the Mann–Whitney U-test. *P < 0.01; NS, not
significant.
were collected (Figures 5A,B). Monosaccharide composition
analysis showed that both P1 and P2 contained glucuronic acid
(GlcA), xylose (Xyl), and mannose (Man) (Figure S3; Table 1),
indicating that they contain glucuronoxylomannan (GXM), a
major cryptococcal capsule component (hereafter, P1 and P2 are
designated as H99 GXM and JP02 GXM, respectively). There
were only small differences in the monosaccharide composition
between H99 GXM and JP02 GXM; specifically, the xylose
content of JP02 GXM was higher than that of H99 GXM.
Thus, if differences in GXM account for the difference in
recognition by DCs, these must be at the level of molecular
structure, so we performed further structural analysis by NMR.
Proton nuclear magnetic resonance (1H NMR) analysis showed
that the major difference between the spectrum of H99 GXM
and JP02 GXM was the pattern of methyl protons indicating O-
acetyl groups (Figure 6). The spectrum of H99 GXM contains 2
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FIGURE 5 | Ion-exchange chromatography of EPS fractions from H99
and JP02 cells indicate similar compositions. (A) H99 and (B) JP02.
EPSs were dissolved in 10mM Tris–HCl buffer, applied to a DEAE-Toyopearl
column (180mm × 25mm φ), and eluted with a 600-mL linear gradient
(0–0.5M) of NaCl. Subfractions containing saccharides were monitored by the
phenol–H2SO4 method.
TABLE 1 | Compositions of major extracellular polysaccharides (EPS)
fractions purified from H99 and JP02 strain (molar ratios).
Fractions Glucuronic acida Xylosea Mannosea O-Acetylb
H99 P1 1.0 2.4 4.1 1.5
JP02 P2 1.0 3.5 4.4 1.7
aCalculated by high performance liquid chromatography (HPLC) analysis of aminobenzoic
acid ethyl ester (ABEE)-labeled hydrolysate.
bEstimated by the ratio of acetyl-methyl resonances to anomeric protons of mannose
backbone in the proton nuclear magnetic resonance (1H NMR) spectra.
methyl protons of O-acetyl groups, whereas that of JP02 GXM
contains only one methyl proton (Figures 6Aa,Ba). The methyl
proton detected at 2.21 ppm in JP02 GXM was also detected in
H99 GXM, but H99 GXM had one additional O-acetyl group
detected at 2.18 ppm. However, acetyl contents were almost the
same between H99 GXM and JP02 GXM as estimated by the ratio
of acetyl-methyl resonances to anomeric protons of the mannose
backbone in the 1H NMR spectra (Table 1).
To confirm the glycan structure of H99 and JP02 GXMs,
they were deacetylated by weak alkali hydrolysis and sonicated
to reduce the molecular weight. The 1H NMR spectra
of deacetylated and sonicated H99 GXM and JP02 GXM
(Figures 6Ac,Bc) were almost the same as those previously
reported from serotype A and B (Serotype B is now called
FIGURE 6 | 500-MHz 1H NMR spectra of native and modified GXM
purified from H99 and JP02 strains recorded in D2O at 70
◦C. (A) H99
and (B) JP02. (a) native, (b) O-deacetylated, and (c) O-deacetylated and
sonicated GXM.
C. gattii), respectively (Turner and Cherniak, 1991; Sheng and
Cherniak, 1997). 1H chemical shifts of anomeric protons were
close to values reported previously (Table 2). These results
suggest that H99 GXM has the glycan structure of serotype
A, consistent with chemotype Chem4 (structure reporter group
(SRG) M2: 100%), while JP02 GXM has that of serotype B,
consistent with chemotype Chem7 (SRG M3: 100%) (Cherniak
et al., 1998). The predicted glycan structures of GXMs purified
from H99 and JP02 indicate that the JP02 GXM has one
additional xylose residue (Xyl3 residue) on the mannose
substituted by glucuronic acid (ManA residue) in the repeating
unit compared to the H99 GXM (Figure 7). Mannan backbone
of the JP02 GXM seems to be more shielded from the outer
environments compared with that of the H99 GXM.
O-acetylation Pattern of GXM may be
Involved in Induction of Inflammatory
Cytokine Production from Dendritic Cells
To test whether the O-acetylation pattern in GXM mediates
the recognition by DCs and thus accounts for the differential
recognition of H99 and JP02, we compared the induction efficacy
of native (intact) to deacetylated GXM. The H99 and JP02 GXMs
were deacetylated with weak alkali treatment and confirmed by
1H NMR analysis (Figures 6Ab,Bb). Intact H99 GXM induced
robust IL-6 production from JAWSII DCs, while intact JP02
GXM induced only a small amount of IL-6 release (Figure 8A).
In contrast, IL-6 production was almost completely eliminated
by deacetylation of GXM in both strains. Intact H99 GXM also
induced TNF-α production from JAWSII DCs, while intact JP02
GXM and deacetylated GXM of both strains did not induce
significant production of this cytokine (Figure 8B).
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TABLE 2 | 1H chemical shifts (δ) of anomeric protons in the deacetylated and sonicated glucuronoxylomannan (GXM) isolated from H99 and JP02
(recorded in D2O at 70
◦C).
GXM ManA ManB ManC GlcA Xyl1 Xyl2 Xyl3
H99 5.25 5.32 5.18 4.47 4.50 4.40 –
JP02 5.21 5.33 5.14 4.47 4.50 4.29 4.42
The nomenclature of sugar residues is displayed in the predicted structures of GXMs shown in Figure 7. H99 GXM had one more anomeric proton detected at 5.14 ppm (Figure 6Ac).
It was also detected in the GXM of the other serotype A strain, but was not assigned previously (Sheng and Cherniak, 1997).
FIGURE 7 | Predicted structures of O-deacetylated GXMs purified from
H99 and JP02 strains. (A) H99 and (B) JP02.
Finally, we evaluated the cytokine-inducing capacity of these
GXMs on primary DCs. We used BMDCs of C57BL/6J mice and
focused on production of interleukin-12 (IL-12), an important
cytokine for the protection of mice against C. neoformans
infection (Kawakami et al., 1996). Intact H99 GXM, but not
intact JP02 GXM, induced IL-12p40 release from BMDCs in
a dose-dependent manner (Figure 8C). Furthermore, IL-12p40
release from BMDCs was almost completely absent in response
to deacetylated H99 GXM, consistent with results from JAWSII
DCs. Similarly, intact H99 GXM induced TNF-α release from
BMDCs, while intact JP02 GXM and deacetylated GXM of both
strains did not induce release of this cytokine (Figure 8D). These
results suggest that the O-acetylation pattern in GXMmay play a
key role in the recognition of Cryptococcus by dendritic cells and
subsequent induction of cytokine release.
DISCUSSION
The histopathological features of C. gattii JP02 infection
characterized in this study are similar to infection by R265,
the highly virulent C. gattii strain clinically isolated during the
Canadian outbreak (Cheng et al., 2009; Leongson et al., 2013;
FIGURE 8 | Cytokine release from dendritic cells in response to native
GXM purified from H99 and JP02 strains and the corresponding
O-deacetylated products. IL-6 (A) and TNF-α (B) release from JAWSII cells
(2× 105cells/mL) stimulated by GXMs (50µg/mL). IL-12p40 (C) and TNF-α (D)
release from BMDCs (1× 106cells/mL) stimulated by GXMs. The experiments
were performed in triplicate (means ± SD). Data sets in (A) or (B) were
compared by the unpaired t-test, except for vs. control in (A), which were
compared by the Mann–Whitney U-test. Treatment group means of (C) or (D)
were compared to H99 GXM by the unpaired t-test, except for vs. JP02 at
10µg/mL in (C), which were compared by Welch’s t-test. *P < 0.01; NS, not
significant. Representative data from 3 independent experiments are shown.
Okubo et al., 2013).We found a shorter survival time followingC.
gattii JP02 infection compared with that following C. neoformans
H99 infection. Moreover, CD4 depletion shortened the survival
of mice infected with C. neoformans H99 but had no effect on
mortality of CD4-depleted mice infected with C. gattii JP02.
These results suggest that JP02 is highly virulent even in mice
with functional CD4-positive cells. This difference of virulence
between C. gattii and C. neoformans is consistent with the fact
that C. gattii infection frequently occurs in relatively healthy
people while cryptococcosis due to C. neoformans tends to
occur more frequently in immunocompromised hosts, especially
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HIV-infected patients (Galanis et al., 2009, 2010). Leongson
et al. showed that the similar phenomena using CD4C/HIVMutA
transgenic mice (which exhibit a preferential depletion of CD4+
T cells) infected with H99 or R265 (Leongson et al., 2013). It
was demonstrated that HIV-1 transgene expression augmented
susceptibility to C. neoformans but not C. gattii infection,
and reduced the pulmonary inflammatory cell response by
both depletion of immune cells and diminished production of
chemokines. However, the factors responsible for the differences
in immune response between C. neoformans and C. gattii were
still unclear. Then, we speculated that the reason for the higher
virulence of JP02 may be lack of recognition by host immune
cells and concomitant evasion of phagocytosis. We demonstrate
that the higher virulence of JP02 compared to H99 stems from a
structural difference in the capsular GXM, which greatly reduces
the capacity of JP02 GXM to induce cytokine release from local
lung DCs. Thus, this study identifies the GXM as a key factor
controlling recognition of Cryptococcus by cells contributing
to innate immunity and thus the pathogenicity of different
Cryptococcus species/strains.
We first showed that H99 induced granuloma formation
in the murine lung, while JP02 did not. The less robust
protective inflammatory response in lungs of JP02-infected
mice may account for the higher virulence of C. gattii even
in immunocompetent hosts. We speculated that there is an
impairment of pathogen recognition for JP02. To identify the
molecules (s) conferring recognition (possibly aberrant in JP02),
we compared IL-6 release from cultured mouse JAWSII DCs
induced by H99 and JP02 cells and found that only H99
cells induced this response, suggesting that hypervirulent C.
gattii possesses molecular mechanism to evade recognition.
Further experiments with intact cells and various cellular
fractions identified GMX as the major determinant of host
recognition.
Virulence of cryptococcal pathogens is thought to be partly
dependent on the capsule. It has been shown that the capsule ofC.
neoformans suppresses the host innate immunity by comparing
encapsulated strain to acapsular mutant. Highly encapsulated
strains of cryptococci resists for phagocytosis by immunocyte
compared to the acapsular mutants (Buchanan and Murphy,
1998). An acapsular mutant of C. neoformans activated and
facilitated maturation of human DC, whereas an encapsulated
strain interfered with DC activation andmaturation (Vecchiarelli
et al., 2003). Siddiqui et al. demonstrated that IL-6 plays
an important role in resistance to C. neoformans infection,
and encapsulated strain of C. neoformans induce lower IL-6
production from human peripheral blood mononuclear cells
than acapsular mutant (Siddiqui et al., 2006).
The capsule is composed primarily of two polysaccharides,
GXM (90–95%) and galactoxylomannan (GalXM, 5–8%), in
addition to a smaller proportion of mannoproteins (MP, <1%)
(Zaragoza et al., 2009). GXM is the major component of the
capsule, and it is also secreted abundantly into the ambient
environment (Cherniak and Sundstrom, 1994). The GXM of C.
neoformans has an important role in abolishing host immunity
by inhibiting binding of antibodies and complement C3 (Young
and Kozel, 1993; Cherniak and Sundstrom, 1994). Yauch et al.
has shown that GXM extracted from C. neoformans and C. gattii
inhibits T-cell proliferation directly (Yauch et al., 2006). On the
other hands, the GXM of C. neoformans can induce expression
and release of inflammatory cytokines, such as TNF-α and IL-
6, from human peripheral blood mononuclear cells (Walenkamp
et al., 1999), neutrophils (Retini et al., 1996), leukocytes (Delfino
et al., 1996), and monocytes (Delfino et al., 1997). As H99
and JP02 strains were encapsulated in the lungs of infected
mice, we focused on differences in cell surface and secreted
polysaccharides. We demonstrated that the CPS, EPS, and GXM
fractions from JP02 induced lower levels of proinflammatory
cytokine secretion by DCs than the same fractions of H99
cells. These differences were not due to suppression of cytokine
release, as H99 capsule-induced release was the same in the
presence and absence of JP02 capsule components, but rather
due to lower recognition of JP02 capsule components by DCs
(Figures 3, 4). JP02 GXM also did not induce the production
of IL-12, an important cytokine for protection of mice against
C. neoformans infection, by initiating Th1 immune responses
(Kawakami et al., 1996). Thus, lower induction of DC IL-12p40
production by JP02 GXM may contribute to reduced activation
of cellular immunity and account for the higher virulence of JP02
in immunocompetent hosts. Consistent with this result, CD4
depletion did not influence the survival or fungal burden in mice
infected with JP02 (Figure 1).
To clarify the relationship between GXM structure
and inflammatory cytokine-inducing activity, we prepared
deacetylated GXM and showed that the O-acetylation pattern
affects cytokine release. An aberrant O-acetyl residue in JP02
GXM detected at 2.18 ppm in H99 GXM by 1H NMR may
contribute to a conformational change allowing JP02 cells to
evade recognition by innate immune cells and thus escape
phagocytic elimination by the host. Indeed, O-acetyltransferase-
deficient mutants of C. neoformans were reported to be
hypervirulent against mice compared to wild type C. neoformans,
supporting our hypothesis (Janbon et al., 2001). The O-
acetylation of C. neoformans GXM is involved in the binding of
antibody (Kozel et al., 2003) and the interference of neutrophil
migration by GXM (Ellerbroek et al., 2004).
The locations of the O-acetyl groups in C. neoformans GXM
had not been determined previously, except for one strain of
C. neoformans serotype D (Janbon et al., 2001). According to
that report, the methyl proton detected at 2.18 ppm in the
1H NMR spectrum is the O-acetyl group bound to the C6
position of the mannose residue substituted by a glucuronic
acid at the C2 position. The JP02 GXM has one additional
xylose residue substituted at the C4 position of that mannose
residue compared with H99 GXM (ManA residue displayed
in Figures 7A,B). One possible reason for the defect of this
acetyl residue in the JP02 GXM may be the spatial regulation
around the mannose residue to access the O-acetyltransferase.
However, it remains unclear why the O-acetyl residue detected
in JP02 GXM at 2.20 ppm by 1H NMR is not recognized by
DCs. We speculate that DCs do not recognize the O-acetylated
mannose residue directly, but distinguish the conformational
change in the GXM molecule arising from the difference in O-
acetylation pattern. While the pathogenicity of C. gattii cannot
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be explained entirely by this aberrant acetyl group, our results
strongly suggest that it does contribute to the hypervirulence of
JP02.
Two other capsular components GalXM and MP also play
important roles in immune response. It was shown that MP
is highly immunogenic (Levitz and Specht, 2006) and that
GalXM induces more TNF-α release from whole blood cultures
compared to GXM (Delfino et al., 1996). Compositional and
NMR analysis of the GXM fraction purified in this study
indicate that the GXM was separated successfully from the other
capsule components, such as GalXM and MP. Future studies
on assessment of the immunoreactivity of C. gattii GalXM
and MP may also contribute to unveil the high virulence of
C. gattii.
In conclusion, this is the first report suggesting a possible
role for the GXM O-acetylation pattern in cryptococcal
recognition by dendritic cells, and our data indicate that
the highly virulent C. gattii JP02 strain evades the innate
immune response by altering the structure of GXM. In this
study, we focused on two cryptococcal strains to perform
extensive structural and immunological analysis. Although
further studies are needed to determine whether the O-
acetylation pattern of GXM is important for virulence of
other cryptococcal strains, this work identifies one possible
molecular mechanism determining Cryptococcus virulence in
healthy hosts. Investigation of host factors, such as pattern
recognition receptors that can distinguish the difference in
the GXM O-acetylation pattern among strains, is currently in
progress.
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